News

You can decrease your risk of diseases carried by mosquitoes by taking steps to avoid getting bitten. Officials declare ...
Dr. Harindu Wijesinghe is a medical specialist in Rheumatology and Rehabilitation, as well as in Sports Medicine. He ...
Merck initiates MOBILIZE-1 phase 3 study evaluating dengue vaccine candidate, V181: Rahway, New Jersey Friday, June 13, 2025, 11:00 Hrs [IST] Merck, known as MSD outside of the Un ...
Merck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 ...
The World Health Organization (WHO) Technical Advisory Group on Virus Evolution (TAG-VE) yesterday published a detailed risk ...